Search results for:
baricitinib
baricitinib
| Drug Name |
Form |
Strength |
ARHS |
Blue Ridge |
Caldwell |
Chatham |
Johnston |
Lenoir |
Medical Center |
Nash |
Pardee |
Rex |
Rockingham |
Southeastern |
Wayne |
Youth Behavioral Health |
| Baricitinib |
TABLET, ORAL |
2 mg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Last updated: Aug. 19, 2024
UNC Health
Caution – Category 3: Reproductive Risk Hazardous Medication, see below for exposure mitigation strategies
System Formulary Restriction:
Use of baricitinib is restricted to use for COVID-19 only; Restricted to patients who meet other criteria, as established by the System Anti-Infective P&T Subcommittee.
UNC Health Criteria for Initiation of Baricitinib
Med Center
Adult Inpatients with COVID-19 Guideline
UNC Medical Center Formulary Restriction